Observational studyDiabetes, obesity & metabolism2025

Long-term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli-durability 24-month observational study.

Rayaz A Malik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.